BMBahram Mofid

Bahram Mofid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bahram Mofid has a total of 69 co-authors. Here are the top co-authors by number of shared publications:

  • Abolfazl Razzaghdoust

    Urology and Nephrology Research Center, Research Institute for Urology and Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    10 shared publications
  • Mohsen Bakhshandeh

    Department of Radiology Technology, Allied Medical Faculty, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    5 shared publications
  • Abbas Basiri

    Shahid Beheshti Univ Med Sci, Urol & Nephrol Res Ctr, Tehran, Iran

    2 shared publications
  • Abbas Basiri

    Urology and Nephrology Research Center (UNRC), Research Institute for Urology and Nephrology, Center of Excellence in Urology, Shahid Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran

    2 shared publications
  • Abolfazl Razzaghdoust

    Urology and Nephrology Research Center, Research Institute for Urology and Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    2 shared publications
  • Anya Jafari

    Department of Radiation Oncology, Shohada-e Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    2 shared publications

Latest Publications

  • Plasma-activated medium as a radiosensitizer in bladder cancer: an in vitro study

    by Hanieh Nazem Zomorodi, Seyed Mahmoud Reza Aghamiri, Masoumeh Zangeneh, Aziz Mahmoudzadeh, Fatemeh Pakniyat, HamidReza Ghomi, Abolfazl Razzaghdoust, Bahram Mofid

    Plasma-activated medium (PAM), generated through exposure to cold atmospheric plasma (CAP), has emerged as a novel anticancer approach with promising radiosensitizing properties, offering potential to enhance the therapeutic efficacy of radiotherapy by increasing tumor cell susceptibility to ionizing radiation. This study aimed to evaluate the cytotoxic and radiosensitizing effects of PAM on human bladder cancer cells. Human bladder cancer (EJ138) and normal fibroblast (HFFF-P16) cell lines were treated with PAM, x-ray radiation (2, 4, and 6 Gy), or their combination. Clonogenic survival and flow cytometric apoptosis assays were performed to assess cytotoxicity and cell death mechanisms. Plating efficiency (PE) and survival fraction (SF) were calculated. Radiation alone reduced EJ138 survival in a dose-dependent manner, with SF values of 0.54 (2 Gy), 0.24 (4 Gy), and 0.16 (6 Gy). PAM alone showed moderate cytotoxicity (SF = 0.52), while the combination of PAM and 2 Gy radiation significantly reduced SF to 0.23 ( p < 0.001), comparable to 4 Gy alone. In contrast, normal fibroblasts (HFFF-P16) showed minimal additional sensitivity with combined treatment (SF reduced from 0.73 to 0.50; p = 0.067), indicating cancer-selective radiosensitization. Flow cytometric analysis revealed that PAM combined with radiation increased apoptosis in EJ138 cells (4.03-fold vs. control, p = 0.034), although the increase was not significantly different from that induced by radiation alone. In conclusion, PAM enhances the radiosensitivity of bladder cancer cells, supporting its potential as a selective radiosensitizer. These findings provide a foundation for further in vivo studies and clinical translation in bladder-preserving radiotherapy.

  • A Review of Dysuria in Traditional Persian Medicine

    by Vida Nazari, Bahram Mofid, Homa Hajimehdipoor, Hanieh Babaei, Ghazaleh Heydarirad

    Background: Background: Dysuria is a very prevalent urinary symptom experienced by the majority of people at least once over their lifetime. Despite the advantages of conventional medications for the management of dysuria, in some patients, there is no thoroughly successful treatment, so numerous patients have a tendency to use complementary or traditional treatments. Persian medicine (PM) consists of the sum total of all the knowledge and practices used in identification, prevention, and treatment in Iran from ancient times to the present. Persian Medicine (PM) manuscripts are a valuable source of experiences of Iranian scholars over the centuries, which contain a lot of information about medicinal herbs that have been used for dysuria. Objectives: The goal of this study was to assess the etiology of dysuria, its types, and treatment according to the principles of PM. Methods: A literature search compiled some PM manuscripts, including the Canon of Medicine, Exir-e-Azam, and Tebb-e-Akbari, on the concept of dysuria as a prevalent disorder to review the etiology, types, and management of dysuria by PM scholars' approaches. Results: According to PM manuscripts, there are three main causes of dysuria. Also, dysuria was treated with three major approaches, including lifestyle modification, food substances, medicinal herbs, and finally, manual therapy. Conclusion: In conclusion, it seems while there are flaws in the conventional management of dysuria, and PM recommendations have found empirical support over the centuries, some PM treatments can be helpful to conventional medicine as complementary medicine; however, more studies are necessary to confirm their effectiveness.

  • Evaluating the Efficacy of Barley Water in Alleviating Radiotherapy‐Induced Dysuria in Prostate Cancer Patients: A Randomized Placebo‐Controlled Trial

    by Vida Nazari, Omid Keshavarzian, Mehdi Pasalar, Shadi Ghasemi, Bahram Mofid, Homa Hajimehdipoor, Mohammad Amin Annabi, Ghazaleh Heydarirad

    Background: Radiotherapy is an essential treatment for various cancers, including prostate cancer (PCa), but it can lead to several adverse events, such as dysuria. While there is no gold standard treatment for this condition, some options, including herbal preparations, are suggested in traditional medicine. This study aimed to evaluate the efficacy of barley water compared to placebo in patients with PCa.Methods: This randomized placebo‐controlled study compared an oral barley water decoction to a placebo after adjuvant radiotherapy in patients with PCa at a clinic in Tehran, Iran. Patients received a daily decoction of barley water or placebo for 1 week and were followed for 8 weeks. Patients, physicians, outcome assessors, and statisticians were blinded to the assigned treatment. The primary outcome was radiotherapy‐induced dysuria, measured using the International Prostate Symptom Score (IPSS). Secondary outcomes included quality of life, analgesics use, and adverse events.Results: A total of 90 PCa patients were randomized to barley water (n = 45) or placebo (n = 45). Analyses showed no significant differences in dysuria, quality of life, or analgesic use between the groups. Adverse events were similar for both groups; however, patient satisfaction was significantly higher in the barley water group (p = 0.047).Conclusions: Barley water showed no clinical benefit over placebo in managing radiotherapy‐induced dysuria in PCa patients. This finding underscores the importance of rigorous clinical evaluation of herbal remedies and highlights the need for evidence‐based interventions to ensure patient safety and enhance quality of life.


  • Open Access

    Diffusion-weighted MRI-Derived ADC and tumor volume as predictive imaging markers for neoadjuvant chemotherapy response in muscle-invasive bladder cancer

    by Abolfazl Razzaghdoust, Anya Jafari, Arash Mahdavi, Bahram Mofid, Abbas Basiri

    This prospective study tested the hypothesis that the apparent diffusion coefficient (ADC) value and tumor volume (TV) measured in diffusion-weighted magnetic resonance imaging (DW-MRI) before, during, and after the treatment are quantitative imaging markers to assess tumor response in muscle-invasive bladder cancer (MIBC) patients undergoing neoadjuvant chemotherapy (NAC). Multi-parametric MRI was prospectively done for MIBC patients at 3 time points. Pre-treatment ADC value, pre-treatment TV, as well as, percent of changes (ΔADC%, and ΔTV%) in these parameters at mid- and post-treatment relative to baseline were calculated and compared between the patients with and without clinical complete response (CR). Also, further analysis was carried out based on the groups of patients with and without overall response (OR). Two different methods of ADC estimation including single-slice ADC measurement (ADCsingle-slice) and whole-lesion ADC measurement (ADCwhole-lesion) were used. A total of 50 eligible patients were included in the analysis. Of these, 20 patients (40%) showed clinical CR to treatment, while 30 (60%) did not. Our results showed that although there was no significant difference between the two groups of patients with and without CR in terms of mid-treatment ΔADC% and mid-treatment ΔTV%, significant differences were observed in terms of the pre-treatment ADC (p < 0.01), pre-treatment TV (p < 0.001), post-treatment ΔADC% (p < 0.05), and post-treatment ΔTV% (p < 0.05). The results of the OR-based analysis were in line with the CR-based results. There was also a strong and significant correlation between ADCsingle-slice and ADCwhole-lesion measurements (r > 0.9, P < 0.001). Pre-treatment ADC, pre-treatment TV, post-treatment ΔADC%, and post-treatment ΔTV% could be considered as promising quantitative imaging markers of tumor response in MIBC patients undergoing NAC. Moreover, mid-treatment ΔADC% and mid-treatment ΔTV% should not be used as predictors of tumor response in these patients. Further larger studies are required to confirm these results.


  • Open Access

    Deep CNN-based Fully Automated Segmentation of Pelvic Multi-Organ on CT Images for Prostate Cancer Radiotherapy

    by Bahram Mofid, Sayed Mohammad Modarres Mosalla, Masumeh Goodarzi, Hassan Tavakoli

    Background: Manual delineation of volumes for prostate radiotherapy treatment is a time-consuming task for radiation oncologists and is also prone to variability. Deep learning-based auto-segmentation methods showed promising results with accurate and high-fidelity contours.Objective: The objective of this study was to evaluate the feasibility of a Computed Tomography (CT)-based deep learning auto-segmentation algorithm for multi-organ delineation in prostate radiotherapy.Material and Methods: In this single-institution retrospective study, a total of 118 patients with prostate cancer were included. We applied 3D nnU-net deep convolutional neural network architecture, a self-adapting ensemble method for simultaneous fast and reproducible multi-organ auto-contouring. The dataset was randomly divided into training and test sets from 95 and 23 patients, respectively. Intensity-modulated radiotherapy plans were generated for both manual and automatic delineations using identical optimization settings. Contours were assessed in terms of the Dice Similarity Coefficient (DSC), and average Hausdorff Distance (HD). Dose distributions were additionally evaluated using parameters derived from Dose-Volume Histograms (DVH).Results: On the test set, 3D nnU-net achieved the best performance in the bladder (DSC:0.97, HD:4.13), right femur head (DSC:0.96, HD:3.58), left femur head (DSC:0.96, HD:3.95), rectum (DSC:0.9, HD:10.04), prostate (DSC:0.82, HD:3.68), lymph nodes (DSC:0.77, HD:15.5), and seminal vesicles (DSC:0.69, HD:10.95). DVH parameters of targets and Organ at Risks (OARs) were significantly different except for lymph nodes and femoral heads between treatment plans based on manual and automatic contours. Conclusion: The 3D nnU-net architecture can be successfully used for multi-organ segmentation in the male pelvic area.


  • Open Access

    Intra-prostatic gold fiducial marker insertion for image-guided radiotherapy (IGRT): five-year experience on 795 patients

    by Ali Mahdavi, Bahram Mofid, Farzad Taghizadeh-Hesary

    Introduction: Prostate cancer is the second most commonly diagnosed cancer in males. The use of intra-prostatic fiducial markers (FM) for image-guided radiotherapy (IGRT) has become widespread due to their accuracy, relatively safe use, low cost, and reproducibility. FM provides a tool to monitor prostate position and volume changes. Many studies reported low to moderate rates of complications following FM implantation. In the current study, we present our five years’ experience regarding the insertion technique, technical success, and rates of complication and migration of intraprostatic insertion of FM gold marker. Methods: From January 2018 to January 2023, 795 patients with prostate cancer candidate for IGRT (with or without a history of radical prostatectomy) enrolled in this study. We used three fiducial markers (3*0.6 mm) inserted through an 18-gauge Chiba needle under transrectal ultrasonography (TRUS) guidance. The patients were observed for complications up to seven days after the procedure. Besides, the rate of marker migration was recorded. Results: All procedures were completed successfully, and all patients tolerated the procedure well with minimal discomfort. The rate of sepsis after the procedure was 1%, and transient urinary obstruction was 1.6%. Only two patients experienced marker migration shortly after insertion, and no fiducial migration was reported throughout radiotherapy. No other major complication was recorded. Discussion: TRUS-guided intraprostatic FM implantation is technically feasible, safe, and well-tolerated in most patients. The FM migration can seldom occur, with negligible effects. This study can provide convincing evidence that TRUS-guided intra-prostatic FM insertion is an appropriate choice for IGRT.


  • Open Access

    Improving Quality of Life for Patients with Breast Cancer by Twin Hearts Meditation: A Randomized Clinical Trial

    by Bahram Mofid, Pouran Varvani Farahani, Amir Hossein Khonsari, Rayan Nazmi, Hessam Edin Taherkhaniha, Samira Azghandi

    Background: Concerning the prevalence and complications of breast cancer and its impact on the quality of life. This paper aims to study the effect of twin hearts meditation (as per Sui) on the quality of life among the patients with breast cancer under chemotherapy. Methods: This randomized clinical trial was conducted on 102 breast cancer patients in two groups. The patients answered a demographic information survey and WHO quality of life short form before intervention. The patients in the experimental group received training on twin hearts meditation by the researcher for 30 minutes in the intervention stage, and the patients did meditation 3 times a week for one and half months. The quality of life of the patients was measured before and after the intervention in the experimental and control groups. The data were analysed using SPSS v.20, descriptive statistics, paired t and independent t tests at a P<0.05 significant level.Results: The results showed that before intervention, there was no significant difference between the mean of quality of life in the experimental (81.3 ± 7.1) and (77.9 ± 16.2) control groups (P=0.344), but after intervention there was a significant difference between the mean of quality of life in the experimental (88.9 ± 11.2) and (75.2 ± 14.9) control groups (P 0.001). Conclusion: Twin hearts meditation can improve the quality of life among the patients with breast cancer under chemotherapy. In this regard, it is suggested that twin hearts meditation be considered as a mind-body complementary medicine.


  • Open Access

    Introducing new plan evaluation indices for prostate dose painting IMRT plans based on apparent diffusion coefficient images

    by Saman Moradi, Bijan Hashemi, Mohsen Bakhshandeh, Amin Banaei, Bahram Mofid

    Dose painting planning would be more complicated due to different levels of prescribed doses and more complex evaluation with conventional plan quality indices considering uniform dose prescription. Therefore, we tried to introduce new indices for evaluating the dose distribution conformity and homogeneity of treatment volumes based on the tumoral cell density and relative volumes of each lesion in prostate IMRT. CT and MRI scans of 20 male patients having local prostate cancer were used for IMRT DP planning. Apparent diffusion coefficient (ADC) images were imported to a MATLAB program to identify lesion regions based on ADC values automatically. Regions with ADC values lower than 750 mm2/s and regions with ADC values higher than 750 and less than 1500 mm2/s were considered CTV70Gy (clinical tumor volume with 70 Gy prescribed dose), and CTV60Gy, respectively. Other regions of the prostate were considered as CTV53Gy. New plan evaluation indices based on evaluating the homogeneity (IOE(H)), and conformity (IOE(C)) were introduced, considering the relative volume of each lesion and cellular density obtained from ADC images. These indices were compared with conventional homogeneity and conformity indices and IOEs without considering cellular density. Furthermore, tumor control probability (TCP) was calculated for each patient, and the relationship of the assessed indices were evaluated with TCP values. IOE (H) and IOE (C) with considering cellular density had significantly lower values compared to conventional indices and IOEs without considering cellular density. (P < 0.05). TCP values had a stronger relationship with IOE(H) considering cell density (R2 = -0.415), and IOE(C) without considering cell density (R2 = 0.624). IOE plan evaluation indices proposed in this study can be used for evaluating prostate IMRT dose painting plans. We suggested to consider cell densities in the IOE(H) calculation formula and it’s appropriate to calculate IOE(C) without considering cell density values.


  • Open Access

    The feasibility of a dose painting procedure to treat prostate cancer based on mpMR images and hierarchical clustering

    by Seyed Masoud Rezaeijo, Bijan Hashemi, Bahram Mofid, Mohsen Bakhshandeh, Arash Mahdavi, Mohammad Saber Hashemi

    Background: We aimed to assess the feasibility of a dose painting (DP) procedure, known as simultaneous integrated boost intensity modulated radiation Therapy (SIB-IMRT), for treating prostate cancer with dominant intraprostatic lesions (DILs) based on multi-parametric magnetic resonance (mpMR) images and hierarchical clustering with a machine learning technique.Methods: The mpMR images of 120 patients were used to create hierarchical clustering and draw a dendrogram. Three clusters were selected for performing agglomerative clustering. Then, the DIL acquired from the mpMR images of 20 patients were categorized into three groups to have them treated with a DP procedure being composed of three planning target volumes (PTVs) determined as PTV1, PTV2, and PTV3 in treatment plans. The DP procedure was carried out on the patients wherein a total dose of 80, 85 and 91 Gy were delivered to the PTV1, PTV2, and PTV3, respectively. Dosimetric and radiobiologic parameters [Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP)] of the DP procedure were compared with those of the conventional IMRT and Three-Dimensional Conformal Radiation Therapy (3DCRT) procedures carried out on another group of 20 patients. A post-treatment follow-up was also made four months after the radiotherapy procedures.Results: All the dosimetric variables and the NTCPs of the organs at risks (OARs) revealed no significant difference between the DP and IMRT procedures. Regarding the TCP of three investigated PTVs, significant differences were observed between the DP versus IMRT and also DP versus 3DCRT procedures. At post-treatment follow-up, the DIL volumes and apparent diffusion coefficient (ADC) values in the DP group differed significantly (p-value < 0.001) from those of the IMRT. However, the whole prostate ADC and prostate-specific antigen (PSA) indicated no significant difference (p-value > 0.05) between the DP versus IMRT.Conclusions: The results of this comprehensive clinical trial illustrated the feasibility of our DP procedure for treating prostate cancer based on mpMR images validated with acquired patients’ dosimetric and radiobiologic assessment and their follow-ups. This study confirms significant potential of the proposed DP procedure as a promising treatment planning to achieve effective dose escalation and treatment for prostate cancer.Trial registration: IRCT20181006041257N1; Iranian Registry of Clinical Trials, Registered: 23 October 2019,https://en.irct.ir/trial/34305.


  • Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy

    by Saleh Sandoughdaran, Abolfazl Razzaghdoust, Ali Tabibi, Abbas Basiri, Nasser Simforoosh, Bahram Mofid

    Purpose: To evaluate the feasibility and potential efficacy of nanocurcumin supplementation in patients with localized muscle-invasive bladder cancer (MIBC) undergoing induction chemotherapy. Materials and Methods: In this double-blind, placebo-controlled trial, 26 MIBC patients were randomized to receive either nanocurcumin (180 mg/day) or placebo during the course of chemotherapy. All patients were followed up to four weeks after the end of treatment to assess the complete clinical response to the chemotherapy as primary endpoint. Secondary endpoints were the comparisons of chemotherapy-induced nephrotoxicity, hematologic nadirs, and toxicities between the two groups. Hematologic nadirs and toxicities were assessed during the treatment. Results: Nanocurcumin was well tolerated. The complete clinical response rates were 30.8 and 50% in the placebo and nanocurcumin groups, respectively. Although nanocurcumin was shown to be superior to placebo with respect to complete clinical response rates as the primary endpoint, there was no significant difference between the groups (p = 0.417). No significant difference was also found between the two groups with regard to grade 3/4 renal and hematologic toxicities as well as hematologic nadirs. Conclusion: These preliminary data indicate the feasibility of nanocurcumin supplementation as a complementary therapy in MIBC patients and support further larger studies. Moreover, a substantial translational insight to fill the gap between the experiment and clinical practice in the field is provided.